PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 34.40
-0.30 (-0.86%)
Apr 23, 2026, 9:50 AM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 1.15 billion as of April 22, 2026. Its market cap has increased by 106.12% in one year.
Market Cap
1.15B
Enterprise Value
1.21B
Revenue
362.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.40
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 1.15B, a decrease of -55.79%. That is a compound annual growth rate of -15.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 1.15B | 33.01% |
| Dec 30, 2025 | 861.08M | -8.08% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 256.48B |
| Novartis AG | 221.54B |
| Lonza Group AG | 36.74B |
| Galderma Group AG | 35.81B |
| Tecan Group AG | 1.72B |
| Cosmo | 1.59B |
| Aevis Victoria | 1.16B |
| SKAN Group AG | 1.08B |